Ngā hua rapu kaituhi

1

Endothelial cell dysfunction: a key determinant for the outcome of allogeneic stem cell transplantation mā Thomas Luft, Peter Dreger, Aleksandar Radujkovic

I whakaputaina 2021

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
2

Allogeneic granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells for treatment of engraftment failure after bone marrow transplantation [letter] mā Peter Dreger, Meinolf Suttorp, Torsten Haferlach, H. Löffler, Norbert Schmitz, W Schroyens

I whakaputaina 1993

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
3

Effects of physical exercise on survival after allogeneic stem cell transplantation mā Joachim Wiskemann, Nikolaus Kleindienst, Rea Kuehl, Peter Dreger, Rainer Schwerdtfeger, Martin Bohus

I whakaputaina 2015

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
4

Allogeneic granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells for treatment of engraftment failure after bone marrow transplantation [letter] mā Peter Dreger, Meinolf Suttorp, Torsten Haferlach, H. Löffler, N Schmitz, W Schroyens

I whakaputaina 1993

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
5

Chimeric antigen receptor transduced T cells: Tuning up for the next generation mā Maria‐Luisa Schubert, Jean‐Marc Hoffmann, Peter Dreger, Carsten Müller‐Tidow, Michael Schmitt

I whakaputaina 2017

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
6

$Cellular Immunotherapy for Refractory Diffuse Large B Cell Lymphoma in the Chimeric Antigen Receptor-Engineered T Cell Era: Still a Role for Allogeneic Transplantation?$

Cellular Immunotherapy for Refractory Diffuse Large B Cell Lymphoma in the Chimeric Antigen Receptor-Engineered T Cell Era: Still a Role for Allogeneic Transplantation? mā Peter Dreger, Timothy S. Fenske, Silvia Montoto, Marcelo C. Pasquini, Anna Sureda, Mehdi Hamadani

I whakaputaina 2020

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
7

Autologous progenitor cell transplantation: prior exposure to stem cell- toxic drugs determines yield and engraftment of peripheral blood progenitor cell but not of bone marrow gra... mā Peter Dreger, M. Kloss, Bodil Petersen, Torsten Haferlach, H. Löffler, M. Loeffler, N Schmitz

I whakaputaina 1995

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
8

Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor) [see comments] mā Norbert Schmitz, Peter Dreger, Meinolf Suttorp, EB Rohwedder, Torsten Haferlach, H. Löffler, Ann Hunter, NH Russell

I whakaputaina 1995

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
9

Effects of a partly self-administered exercise program before, during, and after allogeneic stem cell transplantation mā Joachim Wiskemann, Peter Dreger, Rainer Schwerdtfeger, Andrea Bondong, Gerhard Huber, Nikolaus Kleindienst, Cornelia M. Ulrich, Martin Bohus

I whakaputaina 2010

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
10

Cell-based immunotherapy approaches for multiple myeloma mā Katharina Kriegsmann, Mark Kriegsmann, Martin Cremer, Michael Schmitt, Peter Dreger, Hartmut Goldschmidt, Carsten Müller‐Tidow, Michael Hundemer

I whakaputaina 2018

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
11

Side-effect management of chimeric antigen receptor (CAR) T-cell therapy mā Maria‐Luisa Schubert, Michael Schmitt, L. Wang, Carlos A. Ramos, Karin Jordan, Carsten Müller‐Tidow, Peter Dreger

I whakaputaina 2020

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
12

Unmutated immunoglobulin variable heavy-chain gene status remains an adverse prognostic factor after autologous stem cell transplantation for chronic lymphocytic leukemia mā Matthias Ritgen, Alexandra Lange, Stephan Stilgenbauer, Hartmut Döhner, Christian Bretscher, Heidi Bosse, Ariane Stuhr, Michael Kneba, Peter Dreger

I whakaputaina 2003

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
13

Chimeric Antigen Receptor (CAR) T Cell Therapy in Acute Myeloid Leukemia (AML) mā Susanne Hofmann, Maria‐Luisa Schubert, Lei Wang, Bailin He, Brigitte Neuber, Peter Dreger, Carsten Müller‐Tidow, Michael Schmitt

I whakaputaina 2019

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
14

Blocking the CD39/CD73 pathway synergizes with anti-CD20 bispecific antibody in nodal B-cell lymphoma mā Clara Kolbe, Joseph Kauer, Berit J. Brinkmann, Peter Dreger, Wolfgang Huber, Carsten Müller‐Tidow, Sascha Dietrich, Tobias Roider

I whakaputaina 2025

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
15

Effective mobilisation of peripheral blood progenitor cells with 'Dexa-BEAM' and G-CSF: timing of harvesting and composition of the leukapheresis product mā Peter Dreger, Patrick Marquardt, Torsten Haferlach, S. Jacobs, T Mülverstedt, Volker Eckstein, Meinolf Suttorp, H. Löffler, W Müller-Ruchholtz, Norbert Schmitz

I whakaputaina 1993

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
16

Early recurrence or persistence of autoimmune diseases after unmanipulated autologous stem cell transplantation mā H. Euler, A Marmont, Andrea Bacigalupo, S. Fastenrath, Peter Dreger, M. Hoffknecht, AR Zander, Berthold Schalke, Uwe Hahn, R Haas, N Schmitz

I whakaputaina 1996

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
17

Endothelial Vulnerability and Endothelial Damage Are Associated with Risk of Graft-versus-Host Disease and Response to Steroid Treatment mā Sascha Dietrich, Christine S. Falk, Axel Benner, Suzan Karamustafa, Esther Hahn, Mindaugas Andrulis, Ute Hegenbart, Anthony D. Ho, Peter Dreger, Thomas Luft

I whakaputaina 2012

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
18

GSK-3 mediates differentiation and activation of proinflammatory dendritic cells mā Elena Rodionova, Michael Conzelmann, Eugene Maraskovsky, Michael Heß, Michael Kirsch, Thomas Giese, Anthony D. Ho, Margot Zöller, Peter Dreger, Thomas Luft

I whakaputaina 2006

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
19

$Transplant-associated thrombotic microangiopathy is an endothelial complication associated with refractoriness of acute GvHD$

Transplant-associated thrombotic microangiopathy is an endothelial complication associated with refractoriness of acute GvHD mā Markus Zeisbrich, Natália Becker, Axel Benner, Aleksandar Radujkovic, Katrin Schmitt, Jörg Beimler, Anthony D. Ho, Martin Zeier, Peter Dreger, Thomas Luft

I whakaputaina 2017

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
20

High-risk chronic lymphocytic leukemia in the era of pathway inhibitors: integrating molecular and cellular therapies mā Peter Dreger, Paolo Ghia, Johannes Schetelig, Michel van Gelder, Eva Kimby, Mauricette Michallet, Carol Moreno, Tadeusz Robak, Stephan Stilgenbauer, Emili Montserrat

I whakaputaina 2018

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:

Ngā hua rapu - Peter Dreger

Endothelial cell dysfunction: a key determinant for the outcome of allogeneic stem cell transplantation mā Thomas Luft, Peter Dreger, Aleksandar Radujkovic

Allogeneic granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells for treatment of engraftment failure after bone marrow transplantation [letter] mā Peter Dreger, Meinolf Suttorp, Torsten Haferlach, H. Löffler, Norbert Schmitz, W Schroyens

Effects of physical exercise on survival after allogeneic stem cell transplantation mā Joachim Wiskemann, Nikolaus Kleindienst, Rea Kuehl, Peter Dreger, Rainer Schwerdtfeger, Martin Bohus

Allogeneic granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells for treatment of engraftment failure after bone marrow transplantation [letter] mā Peter Dreger, Meinolf Suttorp, Torsten Haferlach, H. Löffler, N Schmitz, W Schroyens

Chimeric antigen receptor transduced T cells: Tuning up for the next generation mā Maria‐Luisa Schubert, Jean‐Marc Hoffmann, Peter Dreger, Carsten Müller‐Tidow, Michael Schmitt

Cellular Immunotherapy for Refractory Diffuse Large B Cell Lymphoma in the Chimeric Antigen Receptor-Engineered T Cell Era: Still a Role for Allogeneic Transplantation? mā Peter Dreger, Timothy S. Fenske, Silvia Montoto, Marcelo C. Pasquini, Anna Sureda, Mehdi Hamadani

Autologous progenitor cell transplantation: prior exposure to stem cell- toxic drugs determines yield and engraftment of peripheral blood progenitor cell but not of bone marrow gra... mā Peter Dreger, M. Kloss, Bodil Petersen, Torsten Haferlach, H. Löffler, M. Loeffler, N Schmitz

Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor) [see comments] mā Norbert Schmitz, Peter Dreger, Meinolf Suttorp, EB Rohwedder, Torsten Haferlach, H. Löffler, Ann Hunter, NH Russell

Effects of a partly self-administered exercise program before, during, and after allogeneic stem cell transplantation mā Joachim Wiskemann, Peter Dreger, Rainer Schwerdtfeger, Andrea Bondong, Gerhard Huber, Nikolaus Kleindienst, Cornelia M. Ulrich, Martin Bohus

Cell-based immunotherapy approaches for multiple myeloma mā Katharina Kriegsmann, Mark Kriegsmann, Martin Cremer, Michael Schmitt, Peter Dreger, Hartmut Goldschmidt, Carsten Müller‐Tidow, Michael Hundemer

Side-effect management of chimeric antigen receptor (CAR) T-cell therapy mā Maria‐Luisa Schubert, Michael Schmitt, L. Wang, Carlos A. Ramos, Karin Jordan, Carsten Müller‐Tidow, Peter Dreger

Chimeric Antigen Receptor (CAR) T Cell Therapy in Acute Myeloid Leukemia (AML) mā Susanne Hofmann, Maria‐Luisa Schubert, Lei Wang, Bailin He, Brigitte Neuber, Peter Dreger, Carsten Müller‐Tidow, Michael Schmitt

Blocking the CD39/CD73 pathway synergizes with anti-CD20 bispecific antibody in nodal B-cell lymphoma mā Clara Kolbe, Joseph Kauer, Berit J. Brinkmann, Peter Dreger, Wolfgang Huber, Carsten Müller‐Tidow, Sascha Dietrich, Tobias Roider

Early recurrence or persistence of autoimmune diseases after unmanipulated autologous stem cell transplantation mā H. Euler, A Marmont, Andrea Bacigalupo, S. Fastenrath, Peter Dreger, M. Hoffknecht, AR Zander, Berthold Schalke, Uwe Hahn, R Haas, N Schmitz

Endothelial Vulnerability and Endothelial Damage Are Associated with Risk of Graft-versus-Host Disease and Response to Steroid Treatment mā Sascha Dietrich, Christine S. Falk, Axel Benner, Suzan Karamustafa, Esther Hahn, Mindaugas Andrulis, Ute Hegenbart, Anthony D. Ho, Peter Dreger, Thomas Luft

GSK-3 mediates differentiation and activation of proinflammatory dendritic cells mā Elena Rodionova, Michael Conzelmann, Eugene Maraskovsky, Michael Heß, Michael Kirsch, Thomas Giese, Anthony D. Ho, Margot Zöller, Peter Dreger, Thomas Luft

Transplant-associated thrombotic microangiopathy is an endothelial complication associated with refractoriness of acute GvHD mā Markus Zeisbrich, Natália Becker, Axel Benner, Aleksandar Radujkovic, Katrin Schmitt, Jörg Beimler, Anthony D. Ho, Martin Zeier, Peter Dreger, Thomas Luft

High-risk chronic lymphocytic leukemia in the era of pathway inhibitors: integrating molecular and cellular therapies mā Peter Dreger, Paolo Ghia, Johannes Schetelig, Michel van Gelder, Eva Kimby, Mauricette Michallet, Carol Moreno, Tadeusz Robak, Stephan Stilgenbauer, Emili Montserrat

Ngā utauta rapu:

Ngā marau whai pānga